Results 41 to 50 of about 23,703 (223)

Effect of CNP-53 on body length and body weight in female CNP-KO and WT rats. [PDF]

, 2018
Effect of CNP-53 on body length and body weight in female CNP-KO and WT rats.
Keisho Hirota (4994384), Koichiro Murakami (5774978), Nobuya Inagaki (108987), Toshihito Fujii (4994393), Kei Enomoto (548372), Takeshi Hanada (2727619), Hiroko Sade (5774981), Akihiro Yasoda (4112263), Takafumi Yotsumoto (4994390), Yohei Ueda (4994381), Ryuichi Nakamura (4518085), Mayumi Furuya (2794603), Naomi Morozumi (4994399), Yugo Kanai (4994405), Kazunori Yoshikiyo (5774975), Toshimasa Jindo (4994387), Sayaka Yoshida (3406), Ichiro Yamauchi (4112260), Yoriko Ueda-Sakane (5774987), Takafumi Yamashita (5774984)   +19 more
core   +1 more source

Efficiency of C-type natriuretic peptide on improvement of Iraqi local ram's epididymal sperms

Open Veterinary Journal
Background: Fertility plays great role in animal reproduction since high quality semen improves sheep industry reproduction. The current worldwide data revealed the closely related of CNP to reproductive function of rams. Aims: Evaluation the effect of
Massar Saeb Khadim, Nazih Wayes Zaid
doaj   +1 more source

Association between migraine and risk of ocular motor cranial nerve palsy

Scientific Reports, 2022
To assess association between migraines and development of ocular motor cranial nerve palsy (CNP) and finding risk factors using the National Sample Cohort database from the Korea National Health Insurance Service.
Soolienah Rhiu, Kyungdo Han, Juhwan Yoo, Kyung-Ah Park, Sei Yeul Oh   +4 more
doaj   +1 more source

Effect of CNP-53 on body length and body weight in male and female CNP-KO rats. [PDF]

, 2018
Effect of CNP-53 on body length and body weight in male and female CNP-KO rats.
Keisho Hirota (4994384), Koichiro Murakami (5774978), Nobuya Inagaki (108987), Toshihito Fujii (4994393), Kei Enomoto (548372), Takeshi Hanada (2727619), Hiroko Sade (5774981), Akihiro Yasoda (4112263), Takafumi Yotsumoto (4994390), Yohei Ueda (4994381), Ryuichi Nakamura (4518085), Mayumi Furuya (2794603), Naomi Morozumi (4994399), Yugo Kanai (4994405), Kazunori Yoshikiyo (5774975), Toshimasa Jindo (4994387), Sayaka Yoshida (3406), Ichiro Yamauchi (4112260), Yoriko Ueda-Sakane (5774987), Takafumi Yamashita (5774984)   +19 more
core   +1 more source

Effects of Salmonella CNP vaccine on anti-OMPs specific IgA antibodies of vaccinated birds. [PDF]

, 2021
At d1 of age birds were allocated into treatment groups: 1) No vaccine, 2) Live vaccine, 3) CNP vaccine, or 4) Live+CNP vaccine. At d1 of age, birds were orally vaccinated with PBS, Live vaccine, or CNP. At d7 of age, the No vaccine, Live vaccine and CNP
Gabriel O. Akerele (11714547), Revathi Shanmugasundaram (176342), Sankar Renu (6983570), Ramesh K. Selvaraj (10305301), Renukaradhy J. Gourapura (11714550), Keila Y. Acevedo-Villanueva (8763321)   +5 more
core   +1 more source

PK parameters of CNP immunoreactivity after a single intravenous administration of CNP(1–22) or ASB20123 in rats. [PDF]

, 2019
PK parameters of CNP immunoreactivity after a single intravenous administration of CNP(1–22) or ASB20123 in rats.
Hiroaki Maeda (1366338), Yoshiharu Minamitake (6392882), Takafumi Yotsumoto (4994390), Akira Yamaki (6392879), Ryuichi Nakamura (4518085), Naomi Morozumi (4994399), Mayumi Furuya (2794603), Kenji Kangawa (167302), Kazunori Yoshikiyo (5774975), Sayaka Yoshida (3406), Toshimasa Jindo (4994387)   +10 more
core   +1 more source

PK parameters of CNP immunoreactivity after a single subcutaneous administration of CNP(1–22) or ASB20123 in rats. [PDF]

, 2019
PK parameters of CNP immunoreactivity after a single subcutaneous administration of CNP(1–22) or ASB20123 in rats.
Hiroaki Maeda (1366338), Yoshiharu Minamitake (6392882), Takafumi Yotsumoto (4994390), Akira Yamaki (6392879), Ryuichi Nakamura (4518085), Naomi Morozumi (4994399), Mayumi Furuya (2794603), Kenji Kangawa (167302), Kazunori Yoshikiyo (5774975), Sayaka Yoshida (3406), Toshimasa Jindo (4994387)   +10 more
core   +1 more source

Nanomaterial Strategies for Pulmonary Delivery of Immunotherapeutics in Lung Cancer Treatment

Advanced Healthcare Materials, EarlyView.
Inhalable immunotherapeutic nanomedicines enable organ‐selective immune modulation by overcoming pulmonary delivery barriers and concentrating therapy within lung tumors. This Review defines how nanomaterial properties govern airway deposition, retention, cellular partitioning, and immune activation across vaccines, checkpoint blockade, STING agonists,
Han Zhang, Wei Tang
wiley   +1 more source

Receptor agonist activity of CNP and its derivatives. [PDF]

, 2019
(A) NPR-B agonist activity of CNP(1–22), CNP(1–22)/ghrelin(12–28), and ASB20123 was evaluated based on cGMP production in CHO cells stably expressing human NPR-B. (B) NPR-A agonist activity of α-hANP, CNP(1–22), CNP(1–22)/ghrelin(12–28), and ASB20123 was
Hiroaki Maeda (1366338), Yoshiharu Minamitake (6392882), Takafumi Yotsumoto (4994390), Akira Yamaki (6392879), Ryuichi Nakamura (4518085), Naomi Morozumi (4994399), Mayumi Furuya (2794603), Kenji Kangawa (167302), Kazunori Yoshikiyo (5774975), Sayaka Yoshida (3406), Toshimasa Jindo (4994387)   +10 more
core   +1 more source

CNP-miR146a Decreases Inflammation in Murine Acute Infectious Lung Injury [PDF]

, 2023
Acute respiratory distress syndrome (ARDS) has approximately 40% in-hospital mortality, and treatment is limited to supportive care. Pneumonia is the underlying etiology in many cases with unrestrained inflammation central to the pathophysiology. We have
Tanner Lehmann, Bradford Smith, Alison M. Wallbank, Alyssa E. Vaughn, Bailey D. Lyttle, Kenneth W. Liechty, Nana Burns, Eva S. Nozik, Christine U. Vohwinkel, Christina Sul, Anisha Apte, James Bardill, Carlos Zgheib   +12 more
core   +1 more source